Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Franck E. Nicolini; H. Jean Khoury; Luke Akard; Delphine Rea; Hagop Kantarjian; Michele Baccarani; Janis Leonoudakis; Adam Craig; Annie Claude Benichou; Jorge Cortes

doi:10.3324/haematol.2012.083006

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Franck E. Nicolini, H. Jean Khoury, Luke Akard, Delphine Rea, Hagop Kantarjian, Michele Baccarani, Janis Leonoudakis, Adam Craig, Annie Claude Benichou, Jorge Cortes

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	e78-e79
Journal	Haematologica
Volume	98
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2012.083006
State	Published - Jul 2013
Externally published	Yes

Keywords

Advanced chronic myeloid leukemia
Dasatinib
Homoharringtonine
Imatinib
Nilotinib
Omacetaxine
Tyrosine kinase inhibitors

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2012.083006

Cite this

Nicolini, F. E., Khoury, H. J., Akard, L., Rea, D., Kantarjian, H., Baccarani, M., Leonoudakis, J., Craig, A., Benichou, A. C., & Cortes, J. (2013). Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. Haematologica, 98(7), e78-e79. https://doi.org/10.3324/haematol.2012.083006

Nicolini, FE, Khoury, HJ, Akard, L, Rea, D, Kantarjian, H, Baccarani, M, Leonoudakis, J, Craig, A, Benichou, AC & Cortes, J 2013, 'Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors', Haematologica, vol. 98, no. 7, pp. e78-e79. https://doi.org/10.3324/haematol.2012.083006

@article{5e2f3de068f846e09eeccb543f444ab8,

title = "Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors",

keywords = "Advanced chronic myeloid leukemia, Dasatinib, Homoharringtonine, Imatinib, Nilotinib, Omacetaxine, Tyrosine kinase inhibitors",

author = "Nicolini, {Franck E.} and Khoury, {H. Jean} and Luke Akard and Delphine Rea and Hagop Kantarjian and Michele Baccarani and Janis Leonoudakis and Adam Craig and Benichou, {Annie Claude} and Jorge Cortes",

year = "2013",

month = jul,

doi = "10.3324/haematol.2012.083006",

language = "English (US)",

volume = "98",

pages = "e78--e79",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

AU - Nicolini, Franck E.

AU - Khoury, H. Jean

AU - Akard, Luke

AU - Rea, Delphine

AU - Kantarjian, Hagop

AU - Baccarani, Michele

AU - Leonoudakis, Janis

AU - Craig, Adam

AU - Benichou, Annie Claude

AU - Cortes, Jorge

PY - 2013/7

Y1 - 2013/7

KW - Advanced chronic myeloid leukemia

KW - Dasatinib

KW - Homoharringtonine

KW - Imatinib

KW - Nilotinib

KW - Omacetaxine

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84879589256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879589256&partnerID=8YFLogxK

U2 - 10.3324/haematol.2012.083006

DO - 10.3324/haematol.2012.083006

M3 - Letter

C2 - 23753022

AN - SCOPUS:84879589256

SN - 0390-6078

VL - 98

SP - e78-e79

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this